Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doxazosin: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in Humans

NCT03415581 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT03415581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03415581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doxazosin: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in Humans
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 2
Overall status
Terminated
Start date
February 12, 2017
Completion date
December 23, 2019
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder